Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole effects on reward and emotion in healthy volunteers
NCT03681509Completed
- Sponsor
- University of Oxford
- Start
- Sep 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Pramipexole with Placebo (2 arms). Primary endpoint: Change in reward sensitivity on a reinforcement learning task. Started Sep 2018; status: completed.
02
Drugs
pramipexole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03681509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03681509.